22.05.2018 Views

antibioticsbooks

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

190 PART 4 Antifungal Drugs<br />

Moderate: Candida glabrata (can be susceptible<br />

dose-dependent, or resistant), Candida albicans<br />

that are fluconazole-resistant, Fusarium species<br />

Poor: Zygomycetes<br />

Adverse Effects<br />

In addition to the hepatotoxicity, rash, and drug<br />

interactions that are common with this class, voriconazole<br />

has some agent-specific adverse effects<br />

worth watching.<br />

Renal: The cyclodextrin solubilizer that intravenous<br />

voriconazole comes in is known to accumulate<br />

in renal dysfunction. This vehicle is<br />

thought to be nephrotoxic, but it is almost certainly<br />

less nephrotoxic that amphotericin B, so<br />

the use of intravenous voriconazole with renally<br />

insufficient patients is a risk/reward equation<br />

that should be considered with each patient.<br />

Visual effects: Visual effects such as seeing wavy<br />

lines or flashing are very common and doserelated;<br />

they tend to go away with continued<br />

use. Visual hallucinations can also occur but<br />

are less common.<br />

Dosing Issues<br />

Voriconazole has highly variable interpatient pharmacokinetics<br />

and nonlinear elimination, making it<br />

difficult to dose correctly. Some centers monitor voriconazole<br />

trough concentrations, but tests are not yet<br />

widely available. If you are committing your patient<br />

to an extended course of therapy for voriconazole,<br />

consider checking a trough. Also consider trough<br />

concentrations for any patient who is not responding<br />

to therapy or experiencing continual adverse effects.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!